Scribe Therapeutics, Inc.
$14.04
Mkt Cap 265.9M
Biotech developing CRISPR-based gene-editing medicines for disease treatment and prevention.
scribetx.com ↗Summary by The Compound Family, based on the company’s own website
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
Run a full DCF model with Monte Carlo simulation.
Key Metrics
Loading full analysis…
Running full 6-factor analysis…